| 2910.20.00 | 00 | Methyloxirane (Propylene oxide) | kg | 5.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX,P,SG) | 55% |
| 2910.30.00 | 00 | 1-Chloro-2,3-epoxypropane (Epichlorohydrin) | kg | 3.7% | Free (A,AU,BH,CA, CL,E,IL,J,JO, K,MA,MX, P,SG) | 25% |
| 2911.00.10 | 00 | 1,1-Bis(1-methylethoxy)cyclohexane | kg | Free | | 36.5% |
| 2916.20.10 | 00 | (2,3,5,6-Tetrafluoro-4-methylphenyl)methyl- (1 α3 α)-(Z)-( ± )-3-(2-chloro-3,3,3-trifluoro-1- propenyl-2,2-dimethylcyclopropanecarboxylate) (Tefluthrin) | kg | Free | | 25% |
| 2917.19.20 | 00 | Maleic acid; Succinnic acid derived in whole or in part from maleic anhydride or from cyclohexane; Glutaric acid derived in whole or in part from cyclopentanone; and anhydrides, halides, peroxides, peroxyacids and other derivatives of adipic acid, of fumaric acid derived in whole or in part from aromatic hydrocarbons, of maleic acid, of succinnic acid derived in whole or in part from maleic anhydride or from cyclohexane or of glutaric acid derived in whole or in part from cyclopentanone, not elsewhere specified or included: | | | | |
| 2918.99.05 | 00 | p-Anisic acid; Clofibrate; 1,6-Hexanediol bis(3,5-dibutyl-4-hydroxy- phenyl)propionate; and 3-Phenoxybenzoic acid | kg | 5.8% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P,SG) | 15.4￠/kg + 40% |
| 2921.30.05 | 00 | 1,3-Bis(aminoethyl)cyclohexane | kg | Free | | 15.4￠/kg + 53.5% |
| 2922.19.20 | 00 | 4,4'-Bis(dimethylamino)benzhydrol (Michler's hydrol); 5'-[3'-(Dimethylamino)propyl]-10',11'- dihydro-5H'-dibenzo[a,b]cyclohept- en-5'-ol (Dibenzcarbinol); and 1-(p-Nitrophenyl)-2-amino-1,3- propanediol | kg | 5.8% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P,SG) | 15.4￠/kg + 39% |
| 2922.29.13 | 00 | o-Aminophenol; and 2,2-Bis[4-(4-aminophenoxy)phenyl]propane | kg | Free | | 15.4￠/kg + 50% |
| 2922.50.17 | 00 | Dermatological agents and local anesthetics | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P,SG) | 15.4￠/kg + 51.5% |
| 2924.29.31 | 00 | 4-Acetamido-2-aminophenol; p-Acetaminobenzaldehyde; Acetoacetbenzylamide; Acetoacet-5-chloro-2-toluidide; p-Acetoacetophenetidide; N-Acetyl-2,6-xylidine (N-Acetyl-2,6- dimethylaniline); p-Aminobenzoic acid isooctylamide; p-Aminobenzoylaminonaphthalenesulfonic acid; 2-Amino-4-chlorobenzamide; 3-Amino-4-chlorobenzamide; 4-Aminohippuric acid; p-Aminophenylurethane; 1-Benzamido-4-chloroanthraquinone; 1-Benzamido-5-chloroanthraquinone; Benzanilide; 4'-Chloroacetoacetanilide; 3-(N,N-Dihydroxyethylamino)benzanilide; 2,5-Dihydroxy-N-(2-hydroxyethyl)- benzamide; Gentisamide; N,N'-Hexamethylenebis(3,5-di-tert-butyl- 4-hydroxyhydrocinnamamide); 2-(m-Hydroxyanilino)acetamide; Nitra acid amide (1-Amino-9,10-dihydro-￠/(3-methoxypropyl)-4-nitro-9,10-dioxo-2- anthramide); Phenacetin, technical; and β-Resorcylamide | kg | 5.8% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,MA,MX, P,SG) | 15.4￠/kg + 39.5% |
| 2925.19.70 | 00 | N-Chlorosuccinimide; and N,N'-Ethylenebis(5,6-dibromo-2,3- norbornanedicarboximide) | kg | Free | | 25% |
| 2926.30 | | Fenproporex (INN) and its salts; Methadone (INN) intermediate (4-cyano-2-dimethylamino-4,4- diphenylbutane): | | | | |
| 2926.30.20 | 00 | 4-Cyano-2-dimethylamino-4,4-diphenylbutane | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,MA,MX,P) 2.9% (SG) | 15.4￠/kg + 65.5% |
| 2926.90.16 | 00 | [1 α(S*),3 α(Z)]-( ± )-Cyano(3-phenoxyphenyl)- methyl 3-(2-chloro-3,3,3-trifluoro-1-propenyl)- 2,2-dimethylcyclopropanecarboxylate | kg | Free | | 15.4￠/kg + 64.5% |
| 2929.90.05 | 00 | 2,2'-Bis(4-cyanatophenyl)-1,1,1,3,3,3-hexafluoro- propane; 2,2-Bis((4-cyanatophenyl)propane; 1,1-Ethylidenebis(phenyl-4-cyanate); 4,4'-Methylenebis(2,6-dimethylphenylcyanate); and 1,3-Phenylenebis((1-methylethylidenebis)cyanic acid, 1,4-phenylene ester | kg | Free | | 15.4￠/kg + 52% |
| 2930.90.91 | 23 | N,N-Dialkyl (methyl, ethyl, n-propyl or isopropyl)aminoethane-2-thiols and their protonated salts | kg | | | |
| 2931.00.05 | 00 | Diphenyldichlorosilane; and Phenyltrichlorosilane | kg | Free | | 15.4￠/kg + 68.5% |
| 2931.00.70 | 00 | N,N'-Bis(trimethylsilyl)urea; 3-(Hydroxymethylphosphinyl)-1-propanoic acid, 2-hydroxyethyl ester; and 2-Phosphonobutane-1,2,4-tricarboxylic acid and its salts | kg | Free | | 25% |
| 2932.99.08 | 00 | 2-Ethoxy-2,3-dihydro-3,3-dimethyl-5- benzofuranylmethanesulfonate | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX, P,SG) | 15.4￠/kg + 40.5% |
| 2933.39.08 | 00 | 1-(3-Sulfopropyl)pyridinium hydroxide; N,N'-Bis(2,2,6,6-tetramethyl-4-piperidinyl)-1,6- hexanediamine; 3,5-Dimethyl-2-hydroxymethyl-4-methoxy- pyridine (pyrmethyl alcohol); Dipentamethylenethiuram tetrasulfide; 2H-Indol-2-one,1,3-dihydro-1-phenyl-3-(4- pyridinylmethylene); 4-Picolyl chloride hydrochloride; and Piperidinoethyl chloride hydrochloride | kg | Free | | 15.4￠/kg + 52% |
| 2933.71.00 | 00 | 6-Hexanelactam (ε-Caprolactam) | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX,P) 0.2￠/kg + 2.7% (SG) | 15.4￠/kg + 40% |
| 2933.99.06 | 00 | α-Butyl- α-(4-chlorophenyl)-1H-1,2,4- triazole-1- propanenitrile (Myclobutanil); and α-[2-(4-Chlorophenyl)ethyl]- α-phenyl-1H- 1,2,4-triazole-1-propanenitrile (Fenbuconazole) | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX, P,SG) | 15.4￠/kg + 64.5% |
| 2937 | | Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones: | | | | |
| 2937.50.00 | 00 | Prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analogues | g | Free | | 25% |
